Effect of anti diarrhoeal medicine, loperamide, in Autism
Not Applicable
- Conditions
- Health Condition 1: F840- Autistic disorder
- Registration Number
- CTRI/2023/04/051921
- Lead Sponsor
- Central Institute of Psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Children receiving a diagnosis of Autism Spectrum Disorder as per DSM 5
2. Children of either sex aged 4 to 10 years of age
3. Guardian(s) giving written informed consent.
Exclusion Criteria
Children with ASD having intellectual disability, significant sensory and motor impairment, known genetic disorders, seizures at the time of enrolment or other neurological disorders, significant medical or neurological illness (endocrinopathies) or pre-existing constipation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness of Loperamide on social interaction and communication in patients of Autism Spectrum Disorder on SRS2 scale <br/ ><br>Timepoint: baseline, 2weeks, 4weeks
- Secondary Outcome Measures
Name Time Method serum Enkephalin levelsTimepoint: baseline, 4weeks